Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma: A Prospective, Single-arm, Multicenter Study
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
\[Study objectives\] To evaluate the efficacy and safety of the combined treatment of radiotherapy and endoscopic intraductal radiofrequency ablation in patients with locoregional extrahepatic cholangiocarcinoma.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Healthy Volunteers: f
View:
• Patients 20 years of age or older, who voluntarily agree to participate in the study and sign the informed consent.
• Patients with cytopathologically diagnosed inoperable extrahepatic cholangiocarcinoma
Locations
Other Locations
Republic of Korea
National Cancer Center, Korea
RECRUITING
Goyang-si
Contact Information
Primary
Sang Myung Woo, M.D
wsm@ncc.re.kr
82-31-920-1733
Backup
Jung Won Chun, M.D
deli4927@ncc.re.kr
82-31-920-0887
Time Frame
Start Date: 2024-04-01
Estimated Completion Date: 2030-06-30
Participants
Target number of participants: 53
Treatments
Experimental: Experimental
The clinical study will be conducted in the following order. Of patients with extrahepatic cholangiocarcinoma requiring biliary drainage, those who meet the inclusion criteria and consent to the study will be enrolled in the study and hospitalized to undergo endoscopic biliary drainage. The histologic or cytologic examination will be performed at the time of the first biliary drainage, and the extent of the cholangiocarcinoma lesion will be assessed during the procedure. After the diagnosis of extrahepatic cholangiocarcinoma, ID-RFA will be performed, and a biliary stent will be inserted for biliary drainage. Radiotherapy will be performed within 1 month of ID-RFA.
Related Therapeutic Areas
Sponsors
Collaborators: Boston Scientific Corporation
Leads: National Cancer Center, Korea